Skip to main content

Biohybrid Strategies for Vascular Grafts

  • Chapter
  • First Online:
Tissue Engineering

Abstract

Despite the enormous advances realized in cardiology and cardiovascular surgery, approximately 500,000 deaths due to coronary heart disease occur annually in the US [166].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Akowuah EF, Sheridan PJ, Cooper GJ and Newman C, Preventing saphenous vein graft failure: does gene therapy have a role? Ann Thorac Surg. 2003;76(3):959–66.

    PubMed  Google Scholar 

  2. Aldenhoff YB, van Der Veen FH, ter Woorst J, Habets J, Poole-Warren LA and Koole LH, Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. J Biomed Mater Res. 2001;54(2):224–33.

    CAS  PubMed  Google Scholar 

  3. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Lorenz TJ, et al., Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19):2446–54.

    PubMed  Google Scholar 

  4. al-Khaffaf H and Charlesworth D, Albumin-coated vascular prostheses: A five-year follow-up. J Vasc Surg. 1996; 23(4):686–90.

    Google Scholar 

  5. Allen J, Khan S, Lapidos K and Ameer G, Toward engineering a human neoendothelium with circulating progenitor cells. Stem Cells, 2010;28(2):318–28.

    CAS  PubMed  Google Scholar 

  6. Allen J, Khan S, Serrano MC and Ameer G, Characterization of Porcine Circulating Progenitor Cells: Toward a Functional Endothelium. Tissue Eng. 2008;14:183–94.

    CAS  Google Scholar 

  7. Alobaid N, Salacinski HJ, Sales KM, Ramesh B, Kannan RY, Hamilton G, et al., Nanocomposite Containing Bioactive Peptides Promote Endothelialisation by Circulating Progenitor Cells: An In vitro. Eur J Vasc Endovasc Surg. 2006;32(1):76–83.

    CAS  PubMed  Google Scholar 

  8. Anamelechi CC, Clermont EE, Brown MA, Truskey GA and Reichert WM, Streptavidin binding and endothelial cell adhesion to biotinylated fibronectin. Langmuir. 2007; 23(25):12583–8.

    CAS  PubMed  Google Scholar 

  9. Arts CHP, Hedeman Joosten PPA, Blankensteijn JD, Staal FJT, Ng PYY, Heijnen-Snyder GJ, et al., Contaminants from the Transplant Contribute to Intimal Hyperplasia Associated with Microvascular Endothelial Cell. Eur J Vasc Endovasc Surg. 2002;23(1):29–38.

    Google Scholar 

  10. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al., Isolation of putative progenitor endothelial cells for angiogenesis. Science.1997;275(5302):964–7.

    CAS  PubMed  Google Scholar 

  11. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, et al., Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation, 2000;70(1):7–14.

    CAS  PubMed  Google Scholar 

  12. Baguneid MS, Seifalian AM, Salacinski HJ, Murray D, Hamilton G and Walker MG, Tissue engineering of blood vessels. Br J Surg.2006;93(3):282–90.

    CAS  PubMed  Google Scholar 

  13. Banno H, Takei Y, Muramatsu T, Komori K and Kadomatsu K, Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg. 2006;44(3):633–41.

    PubMed  Google Scholar 

  14. Barnes MJ and MacIntyre DE, Platelet-reactivity of isolated constituents of the blood vessel wall. Haemostasis, 1979;8(3–5):158–70.

    CAS  PubMed  Google Scholar 

  15. Bernex F, Mazzucotelli JP, Roudiere JL, Benhaiem-Sigaux N, Leandri J and Loisance D, In vitro endothelialization of carbon-coated Dacron vascular grafts. Int J Artif Organs. 1992;15(3):172–80.

    CAS  PubMed  Google Scholar 

  16. Bhardwaj S, Roy H, Heikura T and Ylä-Herttuala S, VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries. Eur J Clin Invest.2005;35(11):669–76.

    CAS  PubMed  Google Scholar 

  17. Bhat VD, Truskey GA and Reichert WM, Using avidin-mediated binding to enhance initial endothelial cell attachment and spreading. J Biomed Mater Res. 1998;40(1):57–65.

    CAS  PubMed  Google Scholar 

  18. Bos GW, Scharenborg NM, Poot AA, Engbers GH, Terlingen JG, Beugeling T, et al., Adherence and proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate. Tissue Eng.1998;4(3):267–79.

    CAS  PubMed  Google Scholar 

  19. Bosiers M, Deloose K, Verbist J, Schroe H, Lauwers G, Lansink W, et al., Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting. J Vasc Surg.2006;43(2):313–8.

    PubMed  Google Scholar 

  20. Brewster LP, Brey EM, Tassiopoulos AK, Xue L, Maddox E, Armistead D, et al., Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM). Am J Surg.2004;188(5):575–9.

    CAS  PubMed  Google Scholar 

  21. Cagiannos C, Abul-Khoudoud OR, DeRijk W, Shell DH, Jennings LK, Tolley EA, et al., Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J Vasc Surg. 2005;42(5):980–8.

    PubMed  Google Scholar 

  22. Carr HMH, Vohra R, Sharma H, Smyth JV, Rooney OB, Dodd PDF, et al., Endothelial Cell Seeding Kinetics Under Chronic Flow in Prosthetic Grafts. Annals of Vascular Surgery, 1996;10(5):469–75.

    CAS  PubMed  Google Scholar 

  23. Chandy T, Das GS, Wilson RF and Rao GHR, Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular. Biomaterials, 2000;21(7):699–712.

    CAS  PubMed  Google Scholar 

  24. Chen C, Ofenloch JC, Yianni YP, Hanson SR and Lumsden AB, Phosphorylcholine Coating of ePTFE Reduces Platelet Deposition and Neointimal Hyperplasia in Arteriovenous Grafts. J Surg Res. 1998;77(2):119–25.

    CAS  PubMed  Google Scholar 

  25. Chen H, Chen Y, Sheardown H and Brook MA, Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer. Biomaterials, 2005;26(35):7418–24.

    CAS  PubMed  Google Scholar 

  26. Chung HJ and Park TG, Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev.2007;59(4–5):249–62.

    CAS  PubMed  Google Scholar 

  27. Clarke DR, Lust RM, Sun YS, Black KS and Ollerenshaw JD, Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann Thorac Surg. 2001; 71(5):S433–6.

    CAS  PubMed  Google Scholar 

  28. Co M, Tay E, Lee CH, Poh KK, Low A, Lim J, et al., Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary. Am Heart J. 2008;155(1):128–32.

    PubMed  Google Scholar 

  29. Crombez M, Chevallier P, Gaudreault RC, Petitclerc E, Mantovani D and Laroche G, Improving arterial prosthesis neo-endothelialization: application of a proactive VEGF construct onto PTFE surfaces. Biomaterials, 2005;26(35):7402–9.

    CAS  PubMed  Google Scholar 

  30. Daly CD, Campbell GR, Walker PJ and Campbell JH, In vivo engineering of blood vessels. Front Biosci. 2004;9:1915–24.

    CAS  PubMed  Google Scholar 

  31. De Laporte L, Cruz Rea J and Shea LD, Design of modular non-viral gene therapy vectors. Biomaterials, 2006;27(7):947–54.

    PubMed  Google Scholar 

  32. DeLong SA, Moon JJ and West JL, Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials, 2005;26(16):3227–34.

    CAS  PubMed  Google Scholar 

  33. Devine C, McCollum C and North West Femoro-Popliteal Trial P, Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg. 2004;40(5):924–31.

    PubMed  Google Scholar 

  34. Dorrucci V, Griselli F, Petralia G, Spinamano L and Adornetto R, Heparin-bonded expanded polytetrafluoroethylene grafts for infragenicular bypass in patients with critical limb ischemia: 2-year results. J Cardiovasc Surg. 2008;49(2):145–9.

    CAS  Google Scholar 

  35. Eberhart RC, Munro MS, Williams GB, Kulkarni PV, Shannon WA, Brink BE, et al., Albumin adsorption and retention on C18-alkyl-derivatized polyurethane vascular grafts. Artif Organs.1987;11(5):375–82.

    CAS  PubMed  Google Scholar 

  36. Edelman, a ER, Nathan A, Katada M, Gates J and Karnovsky MJ, Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials, 2000;21(22):2279–86.

    Google Scholar 

  37. Edelman ER, Nathan A, Katada M, Gates J and Karnovsky MJ, Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials, 2000;21(22):2279–86.

    CAS  PubMed  Google Scholar 

  38. Edwards WS, Mohtashemi M and Holdefer WF, The importance of proper caliber of lumen in femoral popliteal arterial reconstruction. J Cardiovasc Surg. 1967;8(3):195–7.

    CAS  Google Scholar 

  39. Evangelista RA and Sefton MV, Coating of two polyetoer-polyurethanes and polyethylene with a heparin-poly-(vinyl alcohol) hydrogel. Biomaterials, 1986;7(3):206–11.

    CAS  PubMed  Google Scholar 

  40. Fauvel-Lafève F and Kwang WJ, Microfibrils from the Arterial Subendothelium, in International Review of Cytology; 1999:1–40.

    Google Scholar 

  41. Feng S-S, Zeng W, Teng Lim Y, Zhao L, Yin Win K, Oakley R, et al., Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Nanomedicine.2007;2(3):333–44.

    Google Scholar 

  42. Fleser PS, Nuthakki VK, Malinzak LE, Callahan RE, Seymour ML, Reynolds MM, et al., Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. J Vasc Surg.2004;40(4):803–11.

    PubMed  Google Scholar 

  43. Frost MC and Meyerhoff ME, Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles. J Biomed Mater Res A. 2005;72(4):409–19.

    PubMed  Google Scholar 

  44. Frost MC, Reynolds MM and Meyerhoff ME, Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting. Biomaterials, 2005;26(14):1685–93.

    CAS  PubMed  Google Scholar 

  45. Galli M, Bartorelli A, Bedogni F, DeCesare N, Klugmann S, Maiello L, et al., Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent. J Invasive Cardiol. 2000; 12(9):452–8.

    CAS  PubMed  Google Scholar 

  46. George SJ, Angelini GD, Capogrossi MC and Baker AH, Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration. Gene Ther. 2001;8(9):668–76.

    CAS  PubMed  Google Scholar 

  47. Gong Z and Niklason LE, Blood Vessels Engineered from Human Cells. Trends Cardiovasc Med. 2006;16(5):153–6.

    CAS  PubMed  Google Scholar 

  48. Gorbet MB and Sefton MVMV, Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials, 2004;25(26):5681–703.

    CAS  PubMed  Google Scholar 

  49. Gosselin C, Vorp DA, Warty V, Severyn DA, Dick EK, Borovetz HS, et al., ePTFE coating with fibrin glue, FGF-1, and heparin: effect on retention of seeded endothelial cells. The J Surg Res. 1996;60(2):327–32.

    CAS  Google Scholar 

  50. Gray JL, Kang SS, Zenni GC, Kim DU, Kim PI, Burgess WH, et al., FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia. The J Surg Res. 1994;57(5):596–612.

    CAS  Google Scholar 

  51. Greco RS, Kim HC, Donetz AP and Harvey RA, Patency of a Small Vessel Prosthesis Bonded to Tissue Plasminogen Activator and Iloprost. Ann Vasc Surg.1995;9(2):140–5.

    CAS  PubMed  Google Scholar 

  52. Guidoin R, Chakfe N, Maurel S, How T, Batt M, Marois M, et al., Expanded polytetrafluoroethylene arterial prostheses in humans: histopathological study of 298 surgically excised grafts. Biomaterials, 1993;14(9):678–93.

    CAS  PubMed  Google Scholar 

  53. Hacker TA, Griffin MO, Guttormsen B, Stoker S and Wolff MR, Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo. J Invasive Cardiol.2007;19(6):269–74.

    PubMed  Google Scholar 

  54. Han DK, Park K, Park KD, Ahn K-D and Kim YH, In vivo biocompatibility of sulfonated PEO-grafted polyurethanes for polymer heart valve and vascular graft. Artif Organs.2006;30(12):955–9.

    CAS  PubMed  Google Scholar 

  55. Haruguchi H and Teraoka S, Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a reviewJ Artif Organs. 2003;6(4):227–35.

    Google Scholar 

  56. He H, Shirota T, Yasui H and Matsuda T, Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg. 2003;126(2):455–64.

    PubMed  Google Scholar 

  57. Hedeman Joosten PP, Verhagen HJ, Heijnen-Snyder GJ, Sixma JJ, de Groot PG, Eikelboom BC, et al., Thrombomodulin activity of fat-derived microvascular endothelial cells seeded on expanded polytetrafluorethylene. J Vasc Res. 1999;36(2):91–9.

    Google Scholar 

  58. Heise M, Schmidmaier G, Husmann I, Heidenhain C, Schmidt J, Neuhaus P, et al., PEG-hirudin/iloprost coating of small diameter ePTFE grafts effectively prevents pseudointima and intimal hyperplasia development. Eur J Vasc Endovasc Surg.2006;32(4):418–24.

    CAS  PubMed  Google Scholar 

  59. Herold DA, Keil K and Bruns DE, Oxidation of polyethylene glycols by alcohol dehydrogenase. Biochem Pharmacol. 1989;38(1):73–6.

    CAS  PubMed  Google Scholar 

  60. Hersel U, Dahmen C and Kessler H, RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials, 2003;24(24):4385–415.

    CAS  PubMed  Google Scholar 

  61. Heyligers JMM, Verhagen HJM, Rotmans JI, Weeterings C, de Groot PG, Moll FL, et al., Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. J Vasc Surg.2006;43(3):587–91.

    PubMed  Google Scholar 

  62. Higgins SP, Solan AK and Niklason LE, Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J Biomed Mater Res A. 2003;67(1):295–302.

    PubMed  Google Scholar 

  63. Hoenig MR, Campbell GR, Rolfe BE and Campbell JH, Tissue-engineered blood vessels: alternative to autologous grafts? Arterioscler Thromb Vasc Biol. 2005;25(6):1128–34.

    CAS  PubMed  Google Scholar 

  64. Hoerstrup SP, Cummings Mrcs I, Lachat M, Schoen FJ, Jenni R, Leschka S, et al., Functional Growth in Tissue-Engineered Living, Vascular Grafts: Follow-Up at 100 Weeks in a Large Animal Model. 2006. p. I-159–66.

    Google Scholar 

  65. Hu Y, Litwin T, Nagaraja AR, Kwong B, Katz J, Watson N, et al., Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett.2007;7(10):3056–64.

    CAS  PubMed  Google Scholar 

  66. Huang B, Dreyer T, Heidt M, Yu JCM, Philipp M, Hehrlein FW, et al., Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery. Eur J Cardiothorac Surg. 2002;21(6):1002–8.

    PubMed  Google Scholar 

  67. Hubbell JA, Massia SP, Desai NP and Drumheller PD, Endothelial Cell-Selective Materials for Tissue Engineering in the Vascular Graft Via a New Receptor. Nat Biotech, 1991;9(6):568–72.

    CAS  Google Scholar 

  68. Hwang S and Meyerhoff ME, Polyurethane with tethered copper(II)-cyclen complex: Preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols. Biomaterials, 2008;29(16):2443–52.

    CAS  PubMed  Google Scholar 

  69. Ishihara K, Nomura H, Mihara T, Kurita K, Iwasaki Y and Nakabayashi N, Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res. 1998;39(2):323–30.

    CAS  PubMed  Google Scholar 

  70. Ishii Y, Sakamoto S-I, Kronengold RT, Virmani R, Rivera EA, Goldman SM, et al., A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency. J Thorac Cardiovasc Surg.2008;135(6):1237–45.

    PubMed  Google Scholar 

  71. Ishikawa Y, Sasakawa S, Takase M and Osada Y, Effect of albumin immobilization by plasma polymerization on platelet reactivity. Thromb Res.1984;35(2):193–202.

    CAS  PubMed  Google Scholar 

  72. Iwasaki K, Kojima K, Kodama S, Paz AC, Chambers M, Umezu M, et al., Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation, 2008;118(14 Suppl):52–7.

    Google Scholar 

  73. Iwasaki Y and Ishihara K, Phosphorylcholine-containing polymers for biomedical applications. Anal Bioanal Chem.2005;381(3):534–46.

    CAS  PubMed  Google Scholar 

  74. Jabara R, Chronos N, Hnojewyj O, Rivelli P and Robinson K, Assessment of a novel anti-inflammatory salicylic-acid-based polymer for use in fully biodegradable coronary stents. Cardiovasc Revasc Med. 2007;8(2):131–2.

    Google Scholar 

  75. Jackson JK, Smith J, Letchford K, Babiuk KA, Machan L, Signore P, et al., Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel. Int J Pharm. 2004;283(1):97–109.

    CAS  PubMed  Google Scholar 

  76. Jones MI, McColl IR, Grant DM, Parker KG and Parker TL, Protein adsorption and platelet attachment and activation, on TiN, TiC, and DLC coatings on titanium for cardiovascular applications. J Biomed Mater Res. 2000;52:413–21.

    CAS  PubMed  Google Scholar 

  77. Jordan SW, Faucher KM, Caves JM, Apkarian RP, Rele SS, Sun X-L, et al., Fabrication of a phospholipid membrane-mimetic film on the luminal surface of an ePTFE vascular graft. Biomaterials, 2006;27(18):3473–81.

    CAS  PubMed  Google Scholar 

  78. Jordan SW, Haller CA, Sallach RE, Apkarian RP, Hanson SR and Chaikof EL, The effect of a recombinant elastin-mimetic coating of an ePTFE prosthesis on acute thrombogenicity in a baboon arteriovenous shunt. Biomaterials, 2007;28(6):1191–7.

    CAS  PubMed  Google Scholar 

  79. Kakisis JD, Liapis CD, Breuer C and Sumpio BE, Artificial blood vessel: The Holy Grail of peripheral vascular surgery. J Vasc Surg, 2005;41:349–54.

    PubMed  Google Scholar 

  80. K. Kaladhar CPS, Cell mimetic lateral stabilization of outer cell mimetic bilayer on polymer surfaces by peptide bonding and their blood compatibility. J Biomed Mat Res, 2006. p. 23–35.

    Google Scholar 

  81. Kannan RY, Salacinski HJ, Butler PE, Hamilton G and Seifalian AM, Current status of prosthetic bypass grafts: a review. J Biomed Mat Res Part B Appl Biomater, 2005;74(1):570–81.

    Google Scholar 

  82. Kapadia MR, Chow LW, Tsihlis ND, Ahanchi SS, Eng JW, Murar J, et al., Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J Vasc Surg, 2008;47(1):173–82.

    PubMed  Google Scholar 

  83. Kapadia MR, Popowich DA and Kibbe MR, Modified prosthetic vascular conduits. Circulation, 2008;117(14):1873–82.

    PubMed  Google Scholar 

  84. Kapfer X, Meichelboeck W and Groegler FM, Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: A prospective randomized multicenter study. Eur J Vasc Endovasc Surg. 2006;32(2):155–68.

    CAS  PubMed  Google Scholar 

  85. Karakayali F, Haberal N, Tufan H, Hasirci N, Basaran O, Sevmis S, et al., Evaluation of neointimal hyperplasia on tranilast-coated synthetic vascular grafts: an experimental study. J Investig Surg.2007;20(3):167–73.

    Google Scholar 

  86. Karrer L, Duwe J, Zisch AH, Khabiri E, Cikirikcioglu M, Napoli A, et al., PPS-PEG surface coating to reduce thrombogenicity of small diameter ePTFE vascular grafts. Int J Artif Organs. 2005;28(10):993–1002.

    CAS  PubMed  Google Scholar 

  87. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, et al., Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nature medicine, 2001;7(9):1035–40.

    CAS  PubMed  Google Scholar 

  88. Kibbe MR, Tzeng E, Gleixner SL, Watkins SC, Kovesdi I, Lizonova A, et al., Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg. 2001;34(1):156–65.

    CAS  PubMed  Google Scholar 

  89. Kim W, Jeong MH, Kim KH, Sohn IS, Hong YJ, Park HW, et al., The Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro)-Coated Stent in Acute. J Am Coll Cardiol.2006;47(5):933–8.

    CAS  PubMed  Google Scholar 

  90. Klinkert P, Schepers A, Burger DHC, Bockel JHv and Breslau PJ, Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: Five-year results of a randomized. J Vasc Surg.2003;37(1):149–55.

    PubMed  Google Scholar 

  91. Köhler AS, Parks PJ, Mooradian DL, Rao GHR and Furcht LT, Platelet adhesion to novel phospholipid materials: Modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials. J Biomed Mater Res A. 1996;32(2):237–42.

    Google Scholar 

  92. Kohler TR, Toleikis PM, Gravett DM and Avelar RL, Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh. J Vasc Surg. 2007;45(5):1029–37.

    PubMed  Google Scholar 

  93. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, et al., Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation, 2004;109(14):1769–75.

    CAS  PubMed  Google Scholar 

  94. Konner K, Paclitaxel - a tool to prevent stenosis in vascular access for haemodialysis? Blood Purif. 2006;24(3):287–8.

    PubMed  Google Scholar 

  95. Kottke-Marchant K, Anderson JM, Umemura Y and Marchant RE, Effect of albumin coating on the in vitro blood compatibility of Dacron(R) arterial prostheses. Biomaterials, 1989;10(3):147–55.

    CAS  PubMed  Google Scholar 

  96. Köveker GB, Graham LM, Burkel WE, Sell R, Wakefield TW, Dietrich K, et al., Extracellular matrix preparation of expanded polytetrafluoroethylene grafts seeded with endothelial cells: influence on early platelet deposition, cellular growth, and luminal prostacyclin release. Surgery. 1991;109(3 Pt 1):313–9.

    PubMed  Google Scholar 

  97. Krenning G, Dankers PYW, Jovanovic D, van Luyn MJA and Harmsen MC, Efficient differentiation of CD14^+ monocytic cells into endothelial cells on degradable biomaterials. Biomaterials, 2007;28(8):1470–9.

    CAS  PubMed  Google Scholar 

  98. Kudo FA, Nishibe T, Miyazaki K, Flores J and Yasuda K, Albumin-coated knitted Dacron aortic prosthses. Study of postoperative inflammatory reactions. Int Angiol. 2002; 21(3):214–7.

    CAS  Google Scholar 

  99. Kuiper KK, Robinson KA, Chronos NA, Cui J, Palmer SJ and Nordrehaug JE, Phosphorylcholine-coated metallic stents in rabbit iliac and porcine coronary arteries. Scandinavian cardiovascular journal : SCJ, 1998;32(5):261–8.

    CAS  PubMed  Google Scholar 

  100. Kuji T, Masaki T, Goteti K, Li L, Zhuplatov S, Terry CM, et al., Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis. Kidney Int. 2006;69(12):2179–85.

    CAS  PubMed  Google Scholar 

  101. L’Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, et al., Human tissue-engineered blood vessels for adult arterial revascularization. Nature Medicine, 2006;12(3):361–5.

    PubMed  Google Scholar 

  102. L’Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L and McAllister T, Technology Insight: the evolution of tissue-engineered vascular grafts from research to clinical practice. Nat Clin Pract Cardiovasc Med. 2007;4(7):389–95.

    PubMed  Google Scholar 

  103. L’Heureux N, McAllister TN and de la Fuente LM, Tissue-Engineered Blood Vessel for Adult Arterial Revascularization. N Eng J Med. 2007. p. 1451–3.

    Google Scholar 

  104. L’Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J. 1998;12(1):47–56.

    PubMed  Google Scholar 

  105. Lahtinen M, Blomberg P, Baliulis G, Carlsson F, Khamis H and Zemgulis V, In vivo h-VEGF165 gene transfer improves early endothelialisation and patency in synthetic vascular grafts. Eur J Cardiothorac Surg. 2007. p. 383–90.

    Google Scholar 

  106. Lamm P, Juchem G, Milz S, Schuffenhauer M and Reichart B, Autologous endothelialized vein allograft: a solution in the search for small-caliber grafts in coronary artery bypass graft operations. Circulation, 2001;104(12, 1):108–14.

    Google Scholar 

  107. Laredo J, Xue L, Husak VA, Ellinger J, Singh G, Zamora PO, et al., Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene. J Vasc Surg.2004;39(5):1059–65.

    PubMed  Google Scholar 

  108. Larsen CC, Kligman F, Tang C, Kottke-Marchant K and Marchant RE, A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion. Biomaterials, 2007;28(24):3537–48.

    CAS  PubMed  Google Scholar 

  109. Lee BH, Nam HY, Kwon T, Kim SJ, Kwon GY, Jeon HJ, et al., Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Nephrol Dial Transplant. 2006;21(9):2432–8.

    CAS  PubMed  Google Scholar 

  110. Lewis AL and Stratford PW, Phosphorylcholine-coated stents. J Long Term Eff Med Implants. 2002;12(4):231–50.

    CAS  PubMed  Google Scholar 

  111. Li C, Hill A and Imran M, In vitro and in vivo studies of ePTFE vascular grafts treated with P15 peptide. J Biomater Sci Polym. Ed. 2005;16(7):875–91.

    CAS  PubMed  Google Scholar 

  112. Li J-m, Singh MJ, Nelson PR, Hendricks GM, Itani M, Rohrer MJ, et al., Immobilization of human thrombomodulin to expanded polytetrafluoroethylene. The J Surg Res. 2002;105(2):200–8.

    Google Scholar 

  113. Li L, Terry CM, Shiu Y-TE and Cheung AK, Neointimal hyperplasia associated with synthetic hemodialysis grafts. Kidney Int. 2008;74(10):1247–61.

    CAS  PubMed  Google Scholar 

  114. Lim HJ, Nam HY, Lee BH, Kim DJ, Ko JY and Park J-S, A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Biotechnology progress, 2007;23(3):693–7.

    CAS  PubMed  Google Scholar 

  115. Lin PH, Chen C, Bush RL, Yao Q, Lumsden AB and Hanson SR, Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg.2004;39(6):1322–8.

    PubMed  Google Scholar 

  116. Lin W-C, Tseng C-H and Yang M-C, In-vitro hemocompatibility evaluation of a thermoplastic polyurethane membrane with surface-immobilized water-soluble chitosan and heparin. Macromolecular bioscience, 2005;5(10):1013–21.

    CAS  PubMed  Google Scholar 

  117. Liu SQ, Tieche C and Alkema PK, Neointima formation on vascular elastic laminae and collagen matrices scaffolds implanted in the rat aortae. Biomaterials, 2004; 25(10):1869–82.

    CAS  PubMed  Google Scholar 

  118. Liu Y, Bohr VA and Lansdorp P, Telomere, telomerase and aging. Mech Ageing Dev. 2008;129(1):1–2.

    PubMed  Google Scholar 

  119. Lo C, Li J, Nelson PR, Morris M, Vasiliu C, Rohrer MJ, et al., Superior performance of thrombomodulin coated small caliber ePTFE grafts. J Surg Res. 2003;114(2):263–4.

    Google Scholar 

  120. Long JL and Tranquillo RT, Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol. 2003;22(4):339–50.

    CAS  PubMed  Google Scholar 

  121. Lu A and Sipehia R, Antithrombotic and fibrinolytic system of human endothelial cells seeded on PTFE: the effects of surface modification of PTFE by ammonia plasma treatment and ECM protein coatings. Biomaterials, 2001;22(11):1439–46.

    CAS  PubMed  Google Scholar 

  122. Lu JR, Murphy EF, Su TJ, Lewis AL, Stratford PW and Satija SK, Reduced Protein Adsorption on the Surface of a Chemically Grafted Phospholipid Monolayer. Langmuir. 2001;17:3382–9.

    CAS  Google Scholar 

  123. Luong-Van E, Grøndahl L, Chua KN, Leong KW, Nurcombe V and Cool SM, Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials, 2006;27(9):2042–50.

    CAS  PubMed  Google Scholar 

  124. Lytle BW, Prolonging patency--choosing coronary bypass grafts. N Eng J Med. 2004;351(22):2262–4.

    CAS  Google Scholar 

  125. Maechling-Strasser C, Déjardin P, Galin JC, Schmitt A, Housse-Ferrari V, Sébille B, et al., Synthesis and adsorption of a poly(N-acetylethyleneimine)-polyethyleneoxide-poly (N-acetylethyleneimine) triblock-copolymer at a silica/solution interface. Influence of its preadsorption on platelet adhesion and fibrinogen adsorption. J Biomed Mater Res. 1989;23(12):1395–410.

    CAS  Google Scholar 

  126. Makiyama Y, Toba K, Kato K, Hirono S, Ozawa T, Saigawa T, et al., Imatinib mesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury. Tohoku J Exp Med. 2008;215(4):299–306.

    CAS  PubMed  Google Scholar 

  127. Markway BD, McCarty OJT, Marzec UM, Courtman DW, Hanson SR and Hinds MT, Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Eng. 2008;14(2):97–105.

    CAS  Google Scholar 

  128. Marois Y, Chakfé N, Guidoin R, Duhamel RC, Roy R, Marois M, et al., An albumin-coated polyester arterial graft: in vivo assessment of biocompatibility and healing characteristics. Biomaterials, 1996;17(1):3–14.

    CAS  PubMed  Google Scholar 

  129. Marra KG, Kidani DDA and Chaikof EL, Cytomimetic Biomaterials. 2. In-Situ Polymerization of Phospholipids on a Polymer Surface. Langmuir. 1997;13:5697–701.

    Google Scholar 

  130. Masaki T, Rathi R, Zentner G, Leypoldt JK, Mohammad SF, Burns GL, et al., Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int. 2004;66(5):2061–9.

    CAS  PubMed  Google Scholar 

  131. Matsumura G, Hibino N, Ikada Y, Kurosawa H and Shin’oka T, Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials, 2003;24(13):2303–8.

    CAS  PubMed  Google Scholar 

  132. Matyas L, Berry M, Menyhei G, Tamas L, Acsady G, Cuypers P, et al., The Safety and Efficacy of a Paclitaxel-eluting Wrap for Preventing Peripheral Bypass Graft Stenosis: A 2-Year. Eur J Vasc Endovasc Surg. 2008;35(6):715–22.

    CAS  PubMed  Google Scholar 

  133. Melhem M, Kelly B, Zhang J, Kasting G, Li J, Davis H, et al., Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity. Blood Purif. 2006;24(3):289–98.

    CAS  PubMed  Google Scholar 

  134. Merrill EW, Salzman, E.W., Polyethylene oxide as a biomaterial. ASAIO J, 1983;29(6 ):80–4.

    Google Scholar 

  135. Miller MR, Hanspal IS, Hadoke PWF, Newby DE, Rossi AG, Webb DJ, et al., A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury. Cardiovascular Research, 2003;57(3):853–60.

    CAS  PubMed  Google Scholar 

  136. Miyake T, Aoki M, Shiraya S, Tanemoto K, Ogihara T, Kaneda Y, et al., Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol. 2006;41(3):431–40.

    CAS  PubMed  Google Scholar 

  137. Mizelle SW, Gupta BS and Kasyanov VA. Compliance of small-diameter vascular grafts as a determinant of patency. in Biomedical Engineering Conference, 1995., Proceedings of the 1995 Fourteenth Southern BME Conference, 1995:30–4.

    Google Scholar 

  138. Moon JJ, Lee S-H and West JL, Synthetic biomimetic hydrogels incorporated with ephrin-A1 for therapeutic angiogenesis. Biomacromolecules, 2007;8(1):42–9.

    CAS  PubMed  Google Scholar 

  139. Motlagh D, Allen J, Hoshi R, Yang J, Lui K and Ameer G, Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J Biomed Mater Res A. 2007;82A(4):907–16.

    CAS  Google Scholar 

  140. Mowery KA, H. Schoenfisch M, Saavedra JE, Keefer LK and Meyerhoff ME, Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials, 2000;21(1):9–21.

    Google Scholar 

  141. Najjar SF, Pearce C, Eng J, Aalami O, Kapadia M, Lyle B, et al., Efficacy of perivascular NO-eluting therapies for the prevention of neointimal hyperplasia. J Surg Res. 2006;130(2):205.

    Google Scholar 

  142. Nakao A, Nagaoka S and Mori Y, Hemocompatibility of Hydrogel with Polyethyleneoxide Chains. J Biomater Appl.1987;2(2):219–34.

    CAS  PubMed  Google Scholar 

  143. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, et al., Functional arteries grown in vitro. Science.1999;284(5413):489–93.

    CAS  PubMed  Google Scholar 

  144. Noishiki Y, Ma XH, Yamane Y, Satoh S, Okoshi T, Takahashi K, et al., Succinylated collagen crosslinked by thermal treatment for coating vascular prostheses. Artif Organs.1998;22(8):672–80.

    CAS  PubMed  Google Scholar 

  145. Nugent HM, Rogers C and Edelman ER, Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res. 1999;84(4):384–91.

    CAS  PubMed  Google Scholar 

  146. Oh BK and Meyerhoff ME, Catalytic generation of nitric oxide from nitrite at the interface of polymeric films doped with lipophilic. Biomaterials, 2004;25(2):283–93.

    CAS  PubMed  Google Scholar 

  147. Olsson P, Sanchez J, Mollnes TE and Riesenfeld J, On the blood compatibility of end-point immobilized heparin. J Biomater Sci Polym. Ed. 2000;11(11):1261–73.

    CAS  Google Scholar 

  148. Owens CD, Ho KJ and Conte MS, Lower extremity vein graft failure: a translational approach. Vasc Med. 2008;13:63–74.

    PubMed  Google Scholar 

  149. Park K, Mosher DF and Cooper SL, Acute surface-induced thrombosis in the canine ex vivo model: importance of protein composition of the initial monolayer and platelet activation. J Biomed Mater Res. 1986;20(5):589–612.

    CAS  PubMed  Google Scholar 

  150. Pasic M, Müller-Glauser W, Odermatt B, Lachat M, Seifert B and Turina M, Seeding with omental cells prevents late neointimal hyperplasia in small-diameter Dacron grafts. Circulation, 1995;92(9):2605–16.

    CAS  PubMed  Google Scholar 

  151. Patel A, Fine B, Sandig M and Mequanint K, Elastin biosynthesis: The missing link in tissue-engineered blood vessels. Cardiovasc Res. 2006;71(1):40–9.

    CAS  PubMed  Google Scholar 

  152. Pearce CG, Najjar SF, Kapadia MR, Murar J, Eng J, Lyle B, et al., Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Radic Biol Med. 2008;44(1):73–81.

    CAS  PubMed  Google Scholar 

  153. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al., Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000;95(3):952–8.

    CAS  PubMed  Google Scholar 

  154. Pfeiffer T, Wallich M, Sandmann W, Schrader J and Godecke A, Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded. J Vasc Surg.2006;43(5):1021–7.

    PubMed  Google Scholar 

  155. Phillips DR, Charo IF, Parise LV and Fitzgerald LA, The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988;71:831–43.

    CAS  PubMed  Google Scholar 

  156. Pollara P, Alessandri G, Bonardelli S, Simonini A, Cabibbo E, Portolani N, et al., Complete in vitro prosthesis endothelialization induced by artificial extracellular matrix. J Investig Surg.1999;12(2):81–8.

    CAS  Google Scholar 

  157. Pulfer SK, Ott D and Smith DJ, Incorporation of nitric oxide-releasing crosslinked polyethyleneimine microspheres into vascular grafts. J Biomed Mater Res. 1997;37(2):182–9.

    CAS  PubMed  Google Scholar 

  158. Randone B, Cavallaro G, Polistena A, Cucina A, Coluccia P, Graziano P, et al., Dual role of VEGF in pretreated experimental ePTFE arterial grafts. The J Surg Res. 2005; 127(2):70–9.

    CAS  Google Scholar 

  159. Raybagkar DA, Patchipulusu S, Mast AE and Hall CL, In vitro flow evaluation of recombinant tissue factor pathway inhibitor immobilized on collagen impregnated Dacron. ASAIO J. 2004;50(4):301–5.

    CAS  PubMed  Google Scholar 

  160. Reynolds MM, Hrabie JA, Oh BK, Politis JK, Citro ML, Keefer LK, et al., Nitric oxide releasing polyurethanes with covalently linked diazeniumdiolated secondary amines. Biomacromolecules, 2006;7(3):987–94.

    CAS  PubMed  Google Scholar 

  161. Rhim C and Niklason LE, Tissue engineered vessels: Cells to telomeres. Prog Pediatr Cardiol. 2006;21(2):185–91.

    Google Scholar 

  162. Ripamonti U, Van Den Heever B, Sampath TK, Tucker MM, Rueger DC and Reddi AH, Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors. 1996;13(3–4):273–89.

    CAS  PubMed  Google Scholar 

  163. Rissanen TT and Ylä-Herttuala S, Current Status of Cardiovascular Gene Therapy. Mol Ther. 2007;15(7):1233–47.

    CAS  PubMed  Google Scholar 

  164. Rodríguez G, Gallardo A, Fernández M, Rebuelta M, Buján J, Bellón JM, et al., Hydrophilic polymer drug from a derivative of salicylic acid: synthesis, controlled release studies and biological behavior. Macromol Biosci. 2004;4(6):579–86.

    PubMed  Google Scholar 

  165. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F, et al., CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97(4):314–22.

    CAS  PubMed  Google Scholar 

  166. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al., Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–146.

    PubMed  Google Scholar 

  167. Rotmans JI, Heyligers JMM, Verhagen HJM, Velema E, Nagtegaal MM, de Kleijn DPV, et al., In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation, 2005;112(1):12–8.

    CAS  PubMed  Google Scholar 

  168. Rotmans JI, Pattynama PMT, Verhagen HJM, Hino I, Velema E, Pasterkamp G, et al., Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study. Circulation, 2005;111(12):1537–42.

    CAS  PubMed  Google Scholar 

  169. Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, et al., Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int, 2001;59(6):2325–34.

    CAS  PubMed  Google Scholar 

  170. Rubin BG, Toursarkissian B, Petrinec D, Yang LY, Eisenberg PR and Abendschein DR, Preincubation of Dacron grafts with recombinant tissue factor pathway inhibitor decreases their thrombogenicity in vivo. J Vasc Surg. 1996;24(5):865–70.

    CAS  PubMed  Google Scholar 

  171. San Román J, Buján J, Bellón JM, Gallardo A, Escudero MC, Jorge E, et al., Experimental study of the antithrombogenic behavior of Dacron vascular grafts coated with hydrophilic acrylic copolymers bearing salicylic acid residues. J Biomed Mater Res. 1996;32(1):19–27.

    Google Scholar 

  172. Sarkar S, Schmitz-Rixen T, Hamilton G and Seifalian AM, Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review. Med Biol Eng Comput. 2007;45(4):327–36.

    PubMed  Google Scholar 

  173. Schachner T, Zou Y, Oberhuber A, Mairinger T, Tzankov A, Laufer G, et al., Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts. Eur J Cardiothorac Surg. 2004;25(4):585–90.

    PubMed  Google Scholar 

  174. Schachner T, Oberhuber A, Zou Y, Tzankov A, Ott H, Laufer G, et al., Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts. Eur J Cardiothorac Surg. 2005;27(2):302–6.

    PubMed  Google Scholar 

  175. Schachner T, Pharmacologic inhibition of vein graft neointimal hyperplasia. J Thorac Cardiovasc Surg.2006;131(5):1065–72.

    CAS  PubMed  Google Scholar 

  176. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, et al., Technical factors affecting autogenous vein graft failure: Observations from a large multicenter trial. J Vasc Surg.2007;46(6):1180–90.

    PubMed  Google Scholar 

  177. Scharn DM, Dirven M, Barendregt WB, Boll APM, Roelofs D and van der Vliet JA, Human Umbilical Vein versus Heparin-bonded Polyester for Femoro-popliteal Bypass: 5-year Results of a Prospective. Eur J Vasc Endovasc Surg. 2008;35(1):61–7.

    CAS  PubMed  Google Scholar 

  178. Schmidt SP, Meerbaum SO, Anderson JM, Clarke RE, Zellers RA and Sharp WV, Evaluation of Expanded Polytetrafluoroethylene Arteriovenous Access Grafts onto which Microvessel-Derived Cells were Transplanted to “Improve” Graft Performance: Preliminary Results. Ann Vasc Surg.1998;12(5):405–11.

    CAS  PubMed  Google Scholar 

  179. Seabra AB, de Souza GFP, da Rocha LL, Eberlin MN and de Oliveira MG, S-Nitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery. Nitric Oxide, 2004;11(3):263–72.

    PubMed  Google Scholar 

  180. Shi Q, Wu MHD and Sauvage LR, Clinical and experimental demonstration of complete healing of porous dacron patch grafts used for closure of the arteriotomy after carotid endarterectomy. Ann Vasc Surg.1999;13(3):313–7.

    CAS  PubMed  Google Scholar 

  181. Shin’oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, et al., Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg.2005;129(6):1330–8.

    PubMed  Google Scholar 

  182. Shirota T, He H, Yasui H and Matsuda T, Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng.2003;9(1):127–36.

    CAS  PubMed  Google Scholar 

  183. Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, et al., Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. 1999;68(6):2298–304.

    CAS  PubMed  Google Scholar 

  184. Signore PE, Machan LS, Jackson JK, Burt H, Bromley P, Wilson JE, et al., Complete Inhibition of Intimal Hyperplasia by Perivascular Delivery of Paclitaxel in Balloon-injured Rat Carotid. J Vasc Interv Radiol.2001;12(1):79–88.

    CAS  PubMed  Google Scholar 

  185. Simnick A, Lim DW and Chilkoti A, Biomedical and Biotechnological Applications of Elastin-Like Polypeptides. J Macromol Sci. 2007(47):121–54.

    CAS  Google Scholar 

  186. Simper D, Stalboerger PG, Panetta CJ, Wang S and Caplice NM, Smooth muscle progenitor cells in human blood. Circulation, 2002;106(10):1199–204.

    CAS  PubMed  Google Scholar 

  187. Sinclair J and Salem AK, Rapid localized cell trapping on biodegradable polymers using cell surface derivatization and microfluidic networking. Biomaterials, 2006;27(9):2090–4.

    CAS  PubMed  Google Scholar 

  188. Singh JP, Rothfuss KJ, Wiernicki TR, Lacefield WB, Kurtz WL, Brown RF, et al., Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty. J Am Coll Cardiol.1994;23(3):665–71.

    CAS  PubMed  Google Scholar 

  189. Smith DJ, Chakravarthy D, Pulfer S, Simmons ML, Hrabie JA, Citro ML, et al., Nitric oxide-releasing polymers containing the [N(O)NO]- group. J Med Chem. 1996;39(5):1148–56.

    CAS  PubMed  Google Scholar 

  190. Smith JN and Dasgupta TP, Kinetics and Mechanism of the Decomposition of S-Nitrosoglutathione by -Ascorbic Acid and Copper Ions in Aqueous Solution to Produce Nitric Oxide. Nitric Oxide, 2000;4(1):57–66.

    CAS  PubMed  Google Scholar 

  191. Smith MJ, McClure MJ, Sell SA, Barnes CP, Walpoth BH, Simpson DG, et al., Suture-reinforced electrospun polydioxanone-elastin small-diameter tubes for use in vascular tissue engineering: a feasibility study. Acta Biomater. 2008;4(1):58–66.

    CAS  PubMed  Google Scholar 

  192. Sperling C, König U, Hermel G, Werner C, Müller M, Simon F, et al., Immobilization of human thrombomodulin onto PTFE. J Mater Sci Mater Med. 1997;8(12):789–91.

    CAS  PubMed  Google Scholar 

  193. Sperling C, Schweiss RB, Streller U and Werner C, In vitro hemocompatibility of self-assembled monolayers displaying various functional groups. Biomaterials, 2005;26(33):6547–57.

    CAS  PubMed  Google Scholar 

  194. Sterpetti AV, Cucina A, Randone B, Palumbo R, Stipa F, Proietti P, et al., Growth factor production by arterial and vein grafts: Relevance to coronary artery bypass grafting. Surgery. 1996;120(3):460–7.

    CAS  PubMed  Google Scholar 

  195. Sterpetti AV, Cucina A, Lepidi S, Randone B, Corvino V, D’Angelo LS, et al., Formation of myointimal hyperplasia and cytokine production in experimental vein grafts. Surgery. 1998;123(4):461–9.

    CAS  PubMed  Google Scholar 

  196. Sun LB, Utoh J, Moriyama S, Tagami H, Okamoto K and Kitamura N, Pretreatment of a Dacron graft with tissue factor pathway inhibitor decreases thrombogenicity and neointimal thickness: a preliminary animal study. ASAIO J. 2001;47(4):325–8.

    CAS  PubMed  Google Scholar 

  197. Sun LB, Utoh J, Moriyama S, Tagami H, Okamoto K and Kitamura N, Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits. J Vasc Surg.2001;34(1):151–5.

    CAS  PubMed  Google Scholar 

  198. Swartz DD, Russell JA and Andreadis ST, Engineering of fibrin-based functional and implantable small-diameter blood vessels. J Vasc Surg.2006;43(4):867.

    Google Scholar 

  199. Tai NR, Salacinski HJ, Edwards A, Hamilton G and Seifalian AM. Compliance properties of conduits used in vascular reconstruction. Br J Surg. 2000;87:1516–24.

    CAS  PubMed  Google Scholar 

  200. Taite LJ, Yang P, Jun H-W and West JL, Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J Biomed Mater Res B Appl Biomater. 2008;84(1):108–16.

    PubMed  Google Scholar 

  201. Takahashi K, Adsorption of basic fibroblast growth factor onto Dacron vascular prosthesis and its biological efficacy. Artif Organs.1997;21(9):1041–6.

    CAS  PubMed  Google Scholar 

  202. Tao S-f, Chen L, Zheng Y-x, Xu Y, Chen J and Yu H, Proliferation of endothelial cell on polytetrafluoroethylene vascular graft materials carried VEGF gene plasmid. Journal of Zhejiang University. Science. B, 2006;7(6):421–8.

    Google Scholar 

  203. Tieche C, Alkema PK and Liu SQ, Vascular elastic laminae: anti-inflammatory properties and potential applications to arterial reconstruction. Front Biosci. 2004;9:2205–17.

    CAS  PubMed  Google Scholar 

  204. Tiwari A, Salacinski H, Seifalian AM and Hamilton G, New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc Surgery. 2002;10(3):191–7.

    Google Scholar 

  205. Tseng PY, Rele SS, Sun XL and Chaikof EL, Membrane-mimetic films containing thrombomodulin and heparin inhibit tissue factor-induced thrombin generation in a flow. Biomaterials, 2006;27(12):2637–50.

    CAS  PubMed  Google Scholar 

  206. van der Lei B, Bartels HL, Robinson PH and Bakker WW, Reduced thrombogenicity of vascular prostheses by coating with ADP-ase. Int Angiol. 1992;11(4):268–71.

    PubMed  Google Scholar 

  207. van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J and van Muijen GN, Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood, 1990;75(7):1490–7.

    Google Scholar 

  208. Vara DS, Salacinski HJ, Kannan RY, Bordenave L, Hamilton G and Seifalian AM, Cardiovascular tissue engineering: state of the art. Pathologie-biologie, 2005;53(10):599–612.

    PubMed  Google Scholar 

  209. Vaughn MW, Kuo L and Liao JC, Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am J Phys. 1998;274(6 Pt 2):2163–76.

    Google Scholar 

  210. Verhagen HJ, Heijnen-Snyder GJ, Pronk A, Vroom TM, van Vroonhoven TJ, Eikelboom BC, et al., Thrombomodulin activity on mesothelial cells: perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular grafts. Br J Haematol. 1996;95(3):542–9.

    CAS  PubMed  Google Scholar 

  211. Verhagen HJM, Blankensteijn JD, de Groot PG, Heijnen-Snyder GJ, Pronk A, Vroom TM, et al., In Vivo experiments with mesothelial cell seeded ePTFE vascular grafts. Eur J Vasc Endovasc Surg. 1998;15(6):489–96.

    CAS  PubMed  Google Scholar 

  212. Vermette P, Gauvreau V, Pézolet M and Laroche G, Albumin and fibrinogen adsorption onto phosphatidylcholine monolayers investigated by Fourier transform infrared spectroscopy. Colloids Surf B Biointerfaces. 2003;29(4):285–95.

    CAS  Google Scholar 

  213. Vinard E, Lesèche G, Andreassian B and Costagliola D, In Vitro Endothelialization of PTFE Vascular Grafts: A Comparison of Various Substrates, Cell Densities, and Incubation Times. Ann Vasc Surg.1999;13(2):141–50.

    CAS  PubMed  Google Scholar 

  214. Viscardi PJ, Page EA, Clark HG, Serafin D and Klitzman B, Iloprost in alginate decreases the thrombogenicity of expanded polytetrafluoroethylene. J Reconstr Microsurg. 1997;13(4):303–6.

    CAS  PubMed  Google Scholar 

  215. Vohra RK, Thompson GJ, Sharma H, Carr HM and Walker MG, Fibronectin coating of expanded polytetrafluoroethylene (ePTFE) grafts and its role in endothelial seeding. Artif Organs.1990;14(1):41–5.

    CAS  PubMed  Google Scholar 

  216. Voorhees AB, Jaretzki A and Blakemore AH, The use of tubes constructed from vinyon “N” cloth in bridging arterial defects. Annals of Surgery. 1952;135(3):332–6.

    PubMed  Google Scholar 

  217. Vural KM and Bayazit M, Nitric Oxide: Implications for Vascular and Endovascular Surgery. Eur J Vasc Endovasc Surg. 2001;22(4):285–93.

    CAS  PubMed  Google Scholar 

  218. Wake MC, Gupta PK and Mikos AG, Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplantation, 1996;5(4):465–73.

    CAS  PubMed  Google Scholar 

  219. Walden R, L’Italien GJ, Megerman J and Abbott WM, Matched elastic properties and successful arterial grafting. Arch Surg. 1980;115(10):1166–9.

    CAS  PubMed  Google Scholar 

  220. Walpoth BH and Bowlin GL, The daunting quest for a small diameter vascular graft. Exp Rev Med Dev. 2005;2(6):647–51.

    Google Scholar 

  221. Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache J-C, et al., Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac Cardiovasc Surg.2007;133(5):1163–70.

    CAS  PubMed  Google Scholar 

  222. Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache JC, et al., Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular. J Thorac Cardiovasc Surg.2007;133(5):1163–70.

    CAS  PubMed  Google Scholar 

  223. Wasiewski W, Fasco MJ, Martin BM, Detwiler TC and Fenton JW, Thrombin adsorption to surfaces and prevention with polyethylene glycol 6,000. Thromb Res.1976;8(6):881–6.

    CAS  PubMed  Google Scholar 

  224. Watanabe M, Shin’oka T, Tohyama S, Hibino N, Konuma T, Matsumura G, et al., Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng.2001;7(4):429–39.

    CAS  PubMed  Google Scholar 

  225. Weinberg CB and Bell E, A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231(4736):397–400.

    CAS  PubMed  Google Scholar 

  226. Weiss HJ, Turitto VT and Baumgartner HR, Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood. 1986;67:322–30.

    CAS  PubMed  Google Scholar 

  227. Westedt U, Kalinowski M, Wittmar M, Merdan T, Unger F, Fuchs J, et al., Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J Control Rel. 2007;119(1):41–51.

    CAS  Google Scholar 

  228. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, et al., Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart. 2000;83(3):338–45.

    CAS  PubMed  Google Scholar 

  229. Williams SK, Jarrell BE and Kleinert LB, Endothelial cell transplantation onto polymeric arteriovenous grafts evaluated using a canine model. J Investig Surg.1994;7(6):503–17.

    CAS  Google Scholar 

  230. Wissink MJB, Beernink R, Scharenborg NM, Poot AA, Engbers GHM, Beugeling T, et al., Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. J Control Rel. 2000;67(2–3):141–55.

    CAS  Google Scholar 

  231. Wong G, Li J-m, Hendricks G, Eslami MH, Rohrer MJ and Cutler BS, Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts. J Vasc Surg. 2008;47(3):608–15.

    PubMed  Google Scholar 

  232. Woodhouse KA, Klement P, Chen V, Gorbet MB, Keeley FW, Stahl R, et al., Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings. Biomaterials, 2004;25(19):4543–53.

    CAS  PubMed  Google Scholar 

  233. Wu B, Gerlitz B, Grinnell BW and Meyerhoff ME, Polymeric coatings that mimic the endothelium: Combining nitric oxide release with surface-bound active thrombomodulin. Biomaterials, 2007;28(28):4047–55.

    CAS  PubMed  Google Scholar 

  234. Wyers MC, Phaneuf MD, Rzucidlo EM, Contreras MA, LoGerfo FW and Quist WC, In Vivo Assessment of a Novel Dacron Surface with Covalently Bound Recombinant Hirudin. Cardiovasc Pathol. 1999;8(3):153–9.

    CAS  PubMed  Google Scholar 

  235. Yang Y, Li Q, Ertl HC and Wilson JM, Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995;69(4):2004–15.

    CAS  PubMed  Google Scholar 

  236. Yang J, Motlagh D, Allen JB, Webb AR, Kibbe MR, Aalami O, et al., Modulating Expanded Polytetrafluoroethylene Vascular Graft Host Response via Citric Acid-Based Biodegradable Elastomers. Adv Mater. 2006;18(12):1493–8.

    CAS  Google Scholar 

  237. Yoon C-H, Hur J, Park K-W, Kim J-H, Lee C-S, Oh I-Y, et al., Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation, 2005;112(11):1618–27.

    PubMed  Google Scholar 

  238. Yow KH, Ingram J, Korossis SA, Ingham E and Homer-Vanniasinkam S, Tissue engineering of vascular conduits. Br J Surg.2006;93(6):652–61.

    PubMed  Google Scholar 

  239. Zavan B, Vindigni V, Lepidi S, Iacopetti I, Avruscio G, Abatangelo G, et al., Neoarteries grown in vivo using a tissue-engineered hyaluronan-based scaffold. FASEB J. 2008;22(8):2853–61.

    CAS  PubMed  Google Scholar 

  240. Zhang Q, Wang C, Babukutty Y, Ohyama T, Kogoma M and Kodama M. Biocompatibility evaluation of ePTFE membrane modified with PEG in atmospheric pressure glow discharge. J Biomed Mat Res. 2002;60:502–9.

    CAS  Google Scholar 

  241. Zhu C, Ying D, Mi J, Li L, Zeng W, Hou C, et al., Development of anti-atherosclerotic tissue-engineered blood vessel by A20-regulated endothelial progenitor cells seeding decellularized vascular matrix. Biomaterials, 2008;29(17):2628–36.

    CAS  PubMed  Google Scholar 

  242. Zhu J, Grace M, Casale J, Chang AT, Musco ML, Bordens R, et al., Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum Gene Ther. 1999;10(1):113–21.

    CAS  PubMed  Google Scholar 

  243. Zhu W, Masaki T, Cheung AK and Kern SE, Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cells. Biochem Pharmacol. 2006;72(8):956–64.

    CAS  PubMed  Google Scholar 

  244. Zilla P, Bezuidenhout D and Human P, Prosthetic vascular grafts: Wrong models, wrong questions and no healing. Biomaterials, 2007;28(34):5009–27.

    CAS  PubMed  Google Scholar 

  245. Zisch AH, Zeisberger SM, Ehrbar M, Djonov V, Weber CC, Ziemiecki A, et al., Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials, 2004;25(16):3245–57.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guillermo A. Ameer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

van Lith, R., Ameer, G.A. (2011). Biohybrid Strategies for Vascular Grafts. In: Pallua, N., Suscheck, C. (eds) Tissue Engineering. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02824-3_15

Download citation

Publish with us

Policies and ethics